FMS-like tyrosine kinase 3 ligand (redirect from Flt3 ligand)
ligand (FLT3LG) is a protein which in humans is encoded by the FLT3LG gene. Flt3 ligand (FL) is a hematopoietic four helical bundle cytokine. It is structurally...
7 KB (724 words) - 01:47, 28 August 2024
the brand name Xospata, is an anti-cancer drug. It acts as an inhibitor of FLT3, hence it is a tyrosine kinase inhibitor. It was developed by Astellas Pharma...
8 KB (517 words) - 12:33, 5 August 2024
for oncogenic FLT3, in combination with chemotherapy. The drug is approved for use with a companion diagnostic, the LeukoStrat CDx FLT3 Mutation Assay...
7 KB (597 words) - 06:03, 5 July 2024
tyrosine kinase inhibitor. Its molecular target is FLT3, also known as CD135 which is a proto-oncogene. FLT3 mutations are among the most common mutations...
18 KB (1,251 words) - 04:44, 27 June 2024
and CSF1R also belong to this receptor class. FLT3 protein binds and is activated by the FLT3 ligand; FLT3 protein activation involves its forming dimers...
48 KB (5,760 words) - 23:15, 2 December 2023
Crenolanib (section FLT3: wild-type and mutant)
to FLT3-ITD, FLT3-D835H and FLT3-D835Y with Kd of 0.74 nM, 0.4 nM, and 0.18 nM, respectively. Crenolanib inhibits the phosphorylation of the FLT3-ITD...
19 KB (2,060 words) - 03:27, 3 December 2023
future. FLT3 internal tandem duplications (ITDs) have been shown to confer a poorer prognosis in AML with normal cytogenetics. Several FLT3 inhibitors...
75 KB (7,496 words) - 07:39, 8 October 2024
of cancer. It is an inhibitor of the kinases fms-like tyrosine kinase 3 (FLT3), Janus kinase 2 (JAK2), tropomyosin receptor kinase (trk) A (TrkA), TrkB...
15 KB (1,584 words) - 18:53, 14 May 2024
inhibitor (TKI) of c-Met (HGFR) and VEGFR2, and also inhibits AXL, RET, and FLT3. It was discovered and developed by Exelixis Inc. In November 2012, cabozantinib...
21 KB (1,640 words) - 06:51, 18 September 2024
2020. "VANFLYTA (quizartinib), FDA Approved in the U.S. for Newly Diagnosed FLT3-ITD Positive Acute Myeloid Leukemia, Available at Biologics by McKesson |...
28 KB (2,326 words) - 02:38, 5 September 2024
risk stratification model. IPSS-M determined that multihit TP53 mutations, FLT3 mutations, and partial tandem duplication mutations of KMT2A (MLL) were strong...
64 KB (7,131 words) - 05:23, 11 October 2024
and FLT3. Abu-Duhier FM, Goodeve AC, Care RS, et al. (February 2003). "Mutational analysis of class III receptor tyrosine kinases (C-KIT, C-FMS, FLT3) in...
717 bytes (66 words) - 01:48, 2 December 2023
cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma...
31 KB (2,651 words) - 05:34, 9 August 2024
mainly inhibits Janus kinase 2 (JAK2) and Fms-like tyrosine kinase 3\CD135 (FLT3). Common side effects include diarrhea, low platelet counts, nausea, anemia...
7 KB (315 words) - 01:07, 18 May 2024
common dendritic cell progenitors expressing Flt3 (CD135) receptors are able to give rise to pDCs. Flt3 or CD135 signaling induces differentiation and...
14 KB (1,833 words) - 05:36, 27 December 2023
cells] in murine cultures show phenotypic markers as being CD34-, CD150+, and Flt3- for LTR [long-term reconstitution]. These phenotypic markers are used when...
2 KB (232 words) - 20:14, 16 February 2024
inhibitor targeting multiple tyrosine kinases such as CSF1R, ABL, c-KIT, FLT3, and PDGFR-β. Specifically, it is used for chronic myelogenous leukemia (CML)...
71 KB (6,702 words) - 05:32, 9 August 2024
the t(8;21) because 70% of t(6;9) acute myeloid leukemia patients have the FLT3-ITD mutation (Schwartz et al., 1983, Kottaridis, 2001). The FLT-ITD mutation...
25 KB (3,160 words) - 20:16, 30 November 2023
3; vascular endothelial growth factor receptor (VEGFR) 1, 2, and 3; and FLT3. Its use in IPF is predicated on its inhibition of PDGFR, FGFR, and VEGFR...
34 KB (3,021 words) - 12:39, 5 August 2024
Trial). The inhibitor targets multiple kinase pathways, including BTK and FLT3. Bruton's tyrosine kinase is named for Ogden Bruton, who first described...
27 KB (2,836 words) - 08:04, 9 October 2024
FLT3 interacting zinc finger 1 is a protein that in humans is encoded by the FIZ1 gene. This gene encodes zinc finger protein, which interacts with a receptor...
2 KB (243 words) - 14:54, 12 June 2022
expression of markers such as CD150 and FMS-related tyrosine kinase 3 (FLT3), into CD150+ FLT3-hematopoietic stem cells (HSCs) and CD150- FLT3low multipotent...
32 KB (4,109 words) - 21:03, 6 October 2024
FCRL2 FCRL3 FCRL4 FCRL5 FCRL6 FCRLA FGFR1 FGFR2 FGFR3 FGFR4 FGFRL1 FLT1 FLT3 FLT4 FSTL4 FSTL5 GP6 GPA33 GPR116 GPR125 HEPACAM HLA-DMA HLA-DMB HLA-DQB...
6 KB (493 words) - 18:09, 13 July 2024
PMID 10837469. PDB: 1ETE; Savvides SN, Boone T, Andrew Karplus P (June 2000). "Flt3 ligand structure and unexpected commonalities of helical bundles and cystine...
34 KB (4,157 words) - 07:52, 21 May 2024
[citation needed] The initial treatment with for example BCL2-inhibitors, FLT3-inhibitors, or IDH1/2-inhibitors, may kill leukemic cells. However, pre-leukemic...
29 KB (3,533 words) - 00:48, 30 May 2024
inhibitor of MET and several other receptor tyrosine kinases such as MST1R, FLT3, AXL, MERTK, TEK, ROS1, NTRK1/2/3, and DDR1/2. Meristinib is part of a phase...
4 KB (157 words) - 21:06, 4 September 2024
mice by clonal cells expanded from single CD34+CD38- cells expressing Flk2/Flt3". British Journal of Haematology. 119 (2): 525–534. doi:10.1046/j.1365-2141...
27 KB (3,084 words) - 01:44, 21 December 2023
EPHB6; ERBB2; ERBB3; ERBB4; FER; FES; FGFR1; FGFR2; FGFR3; FGFR4; FGR; FLT1; FLT3; FLT4; FRK; FYN; GSG2; HCK; IGF1R; ILK; INSR; INSRR; IRAK4; ITK; JAK1; JAK2;...
43 KB (5,251 words) - 10:44, 24 June 2024
the disease himself. His team used genetic sequencing and noticed that the FLT3 gene was hyperactive in his leukemia cells and used sunitinib as a treatment...
36 KB (3,447 words) - 05:37, 9 August 2024